MIR34B |
|
microRNA 34b
|
|
|
0.509 |
0.808 |
GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
MIR320A |
|
microRNA 320a
|
|
|
0.526 |
0.808 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
POTEKP |
Q9BYX7
|
POTE ankyrin domain family member K, pseudogene
|
|
|
0.542 |
0.769 |
LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
LINC00273 |
|
long intergenic non-protein coding RNA 273
|
|
|
0.585 |
0.846 |
MIR330 |
|
microRNA 330
|
|
|
0.584 |
0.692 |
OPN1MW3 |
P04001 P0DN77 P0DN78
|
opsin 1, medium wave sensitive 3
|
|
|
0.601 |
0.769 |
BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
LOC107987479 |
|
cytochrome P450 2D6
|
|
|
0.597 |
0.769 |
LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
ECT |
|
centralopathic epilepsy
|
|
|
0.626 |
0.423 |
H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
SEMA3B |
Q13214
|
semaphorin 3B
|
Signaling
|
|
0.633 |
0.615 |
HRES1 |
P13985
|
HTLV-1 related endogenous sequence
|
|
|
0.636 |
0.615 |
FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
SNORD116@ |
|
small nucleolar RNA, C/D box 116 cluster
|
|
|
0.705 |
0.692 |
GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
STH |
Q8IWL8
|
saitohin
|
|
|
0.705 |
0.385 |